3/3
09:43 am
sion
Rating for SION
Low
Report
Rating for SION
3/3
09:43 am
sion
Rating for SION
Low
Report
Rating for SION
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
3/2
01:05 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by Guggenheim.
3/2
01:00 pm
sion
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
Low
Report
Sionna Therapeutics (SION) had its "buy" rating reaffirmed by BTIG Research. They now have a $58.00 price target on the stock.
3/2
12:35 pm
sion
Rating for SION
Low
Report
Rating for SION
2/24
06:03 am
sion
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Medium
Report
Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
1/14
08:04 am
sion
Sionna Therapeutics (NASDAQ:SION) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $58.00 price target on the stock.
High
Report
Sionna Therapeutics (NASDAQ:SION) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $58.00 price target on the stock.
1/14
05:00 am
sion
Rating for SION
High
Report
Rating for SION
1/7
06:44 am
sion
Rating for SION
High
Report
Rating for SION
1/5
07:17 am
sion
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Medium
Report
Sionna Therapeutics (NASDAQ:SION) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..